Executive record
Kevin G. Sarney
Most recent record: Atara Biotherapeutics, Inc. names Kevin G. Sarney interim CFO (named as the incoming officer), effective June 26, 2026. See Atara Biotherapeutics, Inc..
1 verified record
This page lists only verified filing records that name Kevin G. Sarney; it is not a career history. Corrections: the corrections page.